Celldex Therapeutics CLDX
NASDAQ CLDX
$32.18 -0.23 (-0.71%)
At close: Oct 1, 2026 · 4:00 PM EDT

Celldex Therapeutics (CLDX) Cash from Financing Activities (2010 - 2026)

Updated

Celldex Therapeutics (CLDX) recorded Cash from Financing Activities of $324.66 million in Q2 2026, compared with $63,000 a year earlier.

Analysis

Celldex Therapeutics (CLDX) Cash from Financing Activities (2010 - 2026) Analysis & Trends

On a TTM basis, Celldex Therapeutics' Cash from Financing Activities came in at $327.11 million as of Jun 30, 2026; for FY2025, it came in at $2.39 million, down 99.5% from FY2024.

  • Annual Cash from Financing Activities has a five-year compound annual growth rate of -57.5% (FY2020 to FY2025).
  • Across earlier years, Cash from Financing Activities came in at $441.45 million in FY2024 (+102.1%), $218.46 million in FY2023, $4.08 million in FY2022 (-98.5%) and $272.37 million in FY2021 (+59.1%).
  • The Q2 2026 figure is the highest quarterly Cash from Financing Activities since Q1 2024.
  • On a year-over-year basis, Cash from Financing Activities rose in three of the last seven quarters, with growth averaging 51.1%.
  • Peak year-over-year performance for Cash from Financing Activities in the last five years was growth of 868.2% in Q4 2021, against a decline of 100.0% in Q1 2025 at the low end.
  • Per Business Quant, the preceding three quarters came in at $327,000 (Q1 2026), $1.35 million (Q4 2025) and $774,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -8.78 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -5.05 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 1.76 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -2.02 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -47.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -1.48 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 2.34 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -3.66 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -426.70 Mn
10 Celldex Therapeutics 2.54 Bn 2.54 Bn - 324.66 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 324.66 Mn
Mar 31, 2026 327,000.00
Dec 31, 2025 1.35 Mn
Sep 30, 2025 774,000.00
Jun 30, 2025 63,000.00
Mar 31, 2025 202,000.00
Dec 31, 2024 386,000.00
Sep 30, 2024 1.24 Mn
Jun 30, 2024 3.71 Mn
Mar 31, 2024 436.11 Mn
Dec 31, 2023 217.37 Mn
Sep 30, 2023 257,000.00
Jun 30, 2023 133,000.00
Mar 31, 2023 694,000.00
Dec 31, 2022 1.40 Mn
Sep 30, 2022 2.31 Mn
Jun 30, 2022 71,000.00
Mar 31, 2022 304,000.00
Dec 31, 2021 426,000.00
Sep 30, 2021 271.90 Mn
API Access

Celldex Therapeutics Cash from Financing Activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=CLDX&period=max&api_key=YOUR_API_KEY